159 related articles for article (PubMed ID: 28587368)
1. Evaluation of the effect of recombinant thrombomodulin on a lipopolysaccharide-induced murine sepsis model.
Takehara K; Murakami T; Kuwahara-Arai K; Iba T; Nagaoka I; Sakamoto K
Exp Ther Med; 2017 Jun; 13(6):2969-2974. PubMed ID: 28587368
[TBL] [Abstract][Full Text] [Related]
2. Effects of Thrombomodulin in Reducing Lethality and Suppressing Neutrophil Extracellular Trap Formation in the Lungs and Liver in a Lipopolysaccharide-Induced Murine Septic Shock Model.
Kato Y; Nishida O; Kuriyama N; Nakamura T; Kawaji T; Onouchi T; Hasegawa D; Shimomura Y
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066510
[TBL] [Abstract][Full Text] [Related]
3. Recombinant thrombomodulin attenuates hyper-inflammation and glycocalyx damage in a murine model of Streptococcus pneumoniae-induced sepsis.
Watanabe E; Akamatsu T; Ohmori M; Kato M; Takeuchi N; Ishiwada N; Nishimura R; Hishiki H; Fujimura L; Ito C; Hatano M
Cytokine; 2022 Jan; 149():155723. PubMed ID: 34662822
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of recombinant thrombomodulin for lung injury after pneumonectomy via inhibition of high-mobility group box 1 in mice.
Takahashi Y; Matsutani N; Dejima H; Nakayama T; Okamura R; Uehara H; Kawamura M
J Trauma Acute Care Surg; 2016 Nov; 81(5):868-875. PubMed ID: 27504958
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro effects of the anticoagulant, thrombomodulin, on the inflammatory response in rodent models.
Hagiwara S; Iwasaka H; Matsumoto S; Hasegawa A; Yasuda N; Noguchi T
Shock; 2010 Mar; 33(3):282-8. PubMed ID: 19536047
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human soluble thrombomodulin decreases the plasma high-mobility group box-1 protein levels, whereas improving the acute liver injury and survival rates in experimental endotoxemia.
Nagato M; Okamoto K; Abe Y; Higure A; Yamaguchi K
Crit Care Med; 2009 Jul; 37(7):2181-6. PubMed ID: 19487933
[TBL] [Abstract][Full Text] [Related]
7. Fh15 Blocks the Lipopolysaccharide-Induced Cytokine Storm While Modulating Peritoneal Macrophage Migration and CD38 Expression within Spleen Macrophages in a Mouse Model of Septic Shock.
Ramos-Benitez MJ; Ruiz-Jimenez C; Rosado-Franco JJ; Ramos-Pérez WD; Mendez LB; Osuna A; Espino AM
mSphere; 2018 Dec; 3(6):. PubMed ID: 30567900
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Thrombomodulin Attenuates Preeclamptic Symptoms by Inhibiting High-Mobility Group Box 1 in Mice.
Oda H; Nagamatsu T; Schust DJ; Cabral H; Miyazaki T; Iriyama T; Kawana K; Osuga Y; Fujii T
Endocrinology; 2021 Apr; 162(4):. PubMed ID: 33406229
[TBL] [Abstract][Full Text] [Related]
9. Recombinant thrombomodulin ameliorates experimental autoimmune encephalomyelitis by suppressing high mobility group box 1 and inflammatory cytokines.
Uzawa A; Mori M; Masuda H; Ohtani R; Uchida T; Kuwabara S
Clin Exp Immunol; 2018 Jul; 193(1):47-54. PubMed ID: 29509323
[TBL] [Abstract][Full Text] [Related]
10. Delayed administration of D-Ala2-D-Leu5-enkephalin, a delta-opioid receptor agonist, improves survival in a rat model of sepsis.
Tang CW; Feng WM; Du HM; Bao Y; Zhu M
Tohoku J Exp Med; 2011 May; 224(1):69-76. PubMed ID: 21551984
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human soluble thrombomodulin prevents acute lung injury in a rat cardiopulmonary bypass model.
Hirao S; Minakata K; Masumoto H; Yamazaki K; Ikeda T; Minatoya K; Sakata R
J Thorac Cardiovasc Surg; 2017 Dec; 154(6):1973-1983.e1. PubMed ID: 28645823
[TBL] [Abstract][Full Text] [Related]
12. Effects of recombinant human soluble thrombomodulin on neutrophil extracellular traps in the kidney of a mouse model of endotoxin shock.
Harada T; Shimomura Y; Nishida O; Maeda M; Kato Y; Nakamura T; Kuriyama N; Komura H
Fujita Med J; 2023 Aug; 9(3):225-230. PubMed ID: 37554943
[TBL] [Abstract][Full Text] [Related]
13. COMBINATION THERAPY WITH A SENSE OLIGONUCLEOTIDE TO INDUCIBLE NITRIC OXIDE SYNTHASE MRNA AND HUMAN SOLUBLE THROMBOMODULIN IMPROVES SURVIVAL OF SEPSIS MODEL RATS AFTER PARTIAL HEPATECTOMY.
Nakatake R; Okuyama T; Kotsuka M; Ishizaki M; Kitade H; Yoshizawa K; Tolba RH; Nishizawa M; Sekimoto M
Shock; 2023 Jul; 60(1):84-91. PubMed ID: 37141168
[TBL] [Abstract][Full Text] [Related]
14. Soluble thrombomodulin attenuates sinusoidal obstruction syndrome in rat through suppression of high mobility group box 1.
Nakamura K; Hatano E; Miyagawa-Hayashino A; Okuno M; Koyama Y; Narita M; Seo S; Taura K; Uemoto S
Liver Int; 2014 Nov; 34(10):1473-87. PubMed ID: 24498917
[TBL] [Abstract][Full Text] [Related]
15. Involvement of high mobility group box 1 and the therapeutic effect of recombinant thrombomodulin in a mouse model of severe acute respiratory distress syndrome.
Kudo D; Toyama M; Aoyagi T; Akahori Y; Yamamoto H; Ishii K; Kanno E; Maruyama R; Kaku M; Kushimoto S; Kawakami K
Clin Exp Immunol; 2013 Aug; 173(2):276-87. PubMed ID: 23607598
[TBL] [Abstract][Full Text] [Related]
16. Effective combination therapy of polymyxin-B direct hemoperfusion and recombinant thrombomodulin for septic shock accompanied by disseminated intravascular coagulation: a historical controlled trial.
Yamato M; Minematsu Y; Fujii J; Mori K; Minato T; Miyagawa S; Fujimura R; Morikage N; Arata Y; Nakano C; Wada A; Ito T
Ther Apher Dial; 2013 Oct; 17(5):472-6. PubMed ID: 24107274
[TBL] [Abstract][Full Text] [Related]
17. Recombinant thrombomodulin improves the visceral microcirculation by attenuating the leukocyte-endothelial interaction in a rat LPS model.
Iba T; Aihara K; Watanabe S; Yanagawa Y; Takemoto M; Yamada A; Yang D
Thromb Res; 2013 Apr; 131(4):295-9. PubMed ID: 23273403
[TBL] [Abstract][Full Text] [Related]
18. Potential effect of recombinant thrombomodulin on ischemia-reperfusion liver injury in rats.
Kimura K; Yoshizumi T; Inokuchi S; Itoh S; Motomura T; Mano Y; Toshima T; Harada N; Harimoto N; Ikegami T; Soejima Y; Maehara Y
Hepatol Res; 2018 Apr; 48(5):391-396. PubMed ID: 29168258
[TBL] [Abstract][Full Text] [Related]
19. Protective Effects of Recombinant Human Soluble Thrombomodulin on Lipopolysaccharide-Induced Acute Kidney Injury.
Nozaki Y; Ri J; Sakai K; Niki K; Funauchi M; Matsumura I
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260474
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human soluble thrombomodulin improved lipopolysaccharide/d-galactosamine-induced acute liver failure in mice.
Osumi W; Jin D; Imai Y; Tashiro K; Li ZL; Otsuki Y; Maemura K; Komeda K; Hirokawa F; Hayashi M; Takai S; Uchiyama K
J Pharmacol Sci; 2015 Dec; 129(4):233-9. PubMed ID: 26712705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
